| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.073 | 0.02 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.14 | 0.02 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.02 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.02 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.072 | 0.03 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.03 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.35 | 0.03 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.076 | 0.03 |